Maximum Payment Adjustments Sample Clauses

Maximum Payment Adjustments. In no event will the royalties payable to Morphic by ▇▇▇▇▇▇▇ pursuant to Section 8.7 (Royalties) for a Product (without giving effect to any reduction pursuant to this Agreement) in a given Calendar Quarter be reduced by more than [***] of the aggregate amount that would otherwise be payable to Morphic in respect such royalties for such Product in such Calendar Quarter as a result of the reductions permitted pursuant to Section 8.8.1 (Reduction for Lack of Valid Claims), Section 8.8.2 (Generic Competition) and Section 8.8.3 (Third Party Payments by ▇▇▇▇▇▇▇). ▇▇▇▇▇▇▇ may carry forward any such reductions permitted under Section 8.8.1 (Reduction for Lack of Valid Claims), Section 8.8.2 (Generic Competition) or Section 8.8.3 (Third Party Payments by ▇▇▇▇▇▇▇) that are incurred or accrued in a Calendar Quarter but are not applied against royalties due to Morphic in such Calendar Quarter as a result of the foregoing floor and apply such amounts against royalties due to Morphic in any subsequent Calendar Quarter until the amount of such reduction has been fully applied against royalties due to Morphic.

Maximum Payment Adjustments. In no event will the [***] royalties payable to C4 in a given Calendar Quarter reduced by more than [***] of the aggregate amount that would otherwise be payable to C4 in respect such [***] royalties in such Calendar Quarter as a result of the reductions permitted pursuant to Section 7.6.4(a) (Generic Competition) and Section 7.6.4(b) (Third Party Payments). Biogen may carry forward any such reductions permitted under Section 7.6.4(a) (Generic Competition) and Section 7.6.4(b) (Third Party Payments) that are incurred or accrued in a Calendar Quarter but are not applied against [***] royalties due to C4 in such Calendar Quarter as a result of the foregoing floor and apply such amounts against [***] royalties due to C4 in any subsequent Calendar Quarter (subject to the minimum floor set forth in this Section 7.6.4(c) (Maximum Royalty Adjustments)) until the amount of such reduction has been fully applied against [***] royalties due to C4.

Maximum Payment Adjustments. In no event will the royalty rate applicable to any Product in a given Calendar Quarter be less than [**] as a result of the aggregate reductions permitted pursuant to Section 8.6.4(a) (Expiration of Valid Claims), Section 8.6.4(b) (Biosimilar Competition) and Section 8.6.4(c) (Third Party Payments).

Maximum Payment Adjustments. In no event will the royalties payable to Catalyst in a given Calendar Quarter be reduced by more than [***] of the aggregate amount that would otherwise be payable to Catalyst in respect of such royalties in such Calendar Quarter (as set forth in TABLE 7.4.1) as a result of the reductions permitted pursuant to Section 7.4.4(a) (Reductions for Patent Expiry, Generic Versions, and Compulsory Licenses) and Section 7.4.4(b) (Third Party Payments). Biogen may carry forward any such reductions permitted under Section 7.4.4(a) (Reductions for Patent Expiry, Generic Versions, and Compulsory Licenses) and Section 7.4.4(b) (Third Party Payments) that are incurred or accrued in a Calendar Quarter but are not applied against royalties due to Catalyst in such Calendar Quarter as a result of the foregoing floor. Biogen may apply such amounts against royalties due to Catalyst in any subsequent Calendar Quarter (subject to the minimum floor set forth in this Section 7.4.4(c) (Maximum Royalty Adjustments)) until the full amount of such reduction has been fully applied against royalties due to Catalyst.

Maximum Payment Adjustments. During the Royalty Term, ▇▇▇▇▇▇▇ shall have the right to adjust or reduce the royalties payable under Clause 5.4.1 pursuant to the provisions of Clauses 5.4.2, 5.4.3, and 5.4.4 provided however, that in no case shall such adjustment or reductions lower the amount of royalty payable under Clause 5.4.1 below [***] of the amount otherwise due. ▇▇▇▇▇▇▇ shall be entitled to carry forward any such reductions permitted under Clauses 5.4.2, 5.4.3, and 5.4.4 that are incurred or accrued in a Calendar Quarter but are not applied against royalties due to LAVA in such Calendar Quarter as a result of the foregoing floor and apply such amounts against royalties due to LAVA in any subsequent Calendar Quarter until the amount of such reduction has been fully applied against royalties due to LAVA.

Maximum Payment Adjustments. (a) The total amount payable by CREDCO to all DealerTrack Companies pursuant to Section 6.4.1 (i) shall not exceed $95,000 during the one-year period beginning on the date on which integration between the DealerTrack Network and the systems through which CREDCO delivers CREDCO Products is complete and during each subsequent one-year period. (b) The total amount payable by CREDCO to all DealerTrack Companies pursuant to Section 6.4.1 (a) and Section 6.4.1 (c), collectively, shall not exceed the sum of (i) the product of the applicable fee under Section 6.4.1 (a) and the average number of credit bureau reports purchased from DT, or from the Repositories using a DT subscriber code, by the Assigned DT Bureau Customers and Subcontracted DT Bureau Customers described in Section 6.4.1 (a) for the full three calendar months prior to the date of this Agreement and (ii) the product of the applicable fee under Section 6.4.1 (c) and the average number of credit bureau reports purchased from DT, or from the Repositories using a DT subscriber code, by the Assigned DT Bureau Customers and Subcontracted DT Bureau Customers described in Section 6.4.1 (c) for the full three calendar months prior to the date of this Agreement.

Maximum Payment Adjustments. [**], in no event will the adjustments under Section 7.5(e)(i), Section 7.5(e)(ii), and Section 7.5(e)(iii) taken together reduce the royalties due to Cyclerion in a country [**] with respect to a Product by more than [**] of the amount that would have been due [**] for such Product in such country but for the application of the reductions in this Section 7.5(e) (the “Reduction Floor”); provided that [**].

Maximum Payment Adjustments